{"id":"treatment-period-jw0201","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Unfortunately, there is limited information available on JW0201's mechanism of action.","oneSentence":"JW0201 is a treatment for Treatment Period, but exact mechanism is unknown.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:40:02.234Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment Period"}]},"trialDetails":[{"nctId":"NCT05814393","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"JW Pharmaceutical","startDate":"2023-01-03","conditions":"Type 2 Diabetes Mellitus","enrollment":200},{"nctId":"NCT05814406","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DM","status":"COMPLETED","sponsor":"JW Pharmaceutical","startDate":"2023-01-12","conditions":"Type 2 Diabetes Mellitus","enrollment":196},{"nctId":"NCT06361277","phase":"PHASE1","title":"To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy Volunteers","status":"COMPLETED","sponsor":"JW Pharmaceutical","startDate":"2023-11-03","conditions":"Healthy","enrollment":56},{"nctId":"NCT05463497","phase":"PHASE1","title":"To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers","status":"COMPLETED","sponsor":"JW Pharmaceutical","startDate":"2022-01-17","conditions":"Healthy","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["JW0201+C2022+C2203"],"phase":"phase_3","status":"active","brandName":"Treatment Period(JW0201)","genericName":"Treatment Period(JW0201)","companyName":"JW Pharmaceutical","companyId":"jw-pharmaceutical","modality":"Small molecule","firstApprovalDate":"","aiSummary":"JW0201 is a treatment for Treatment Period, but exact mechanism is unknown. Used for Treatment Period.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}